ID: ALA2268806

Max Phase: Preclinical

Molecular Formula: C19H29Cl2NO

Molecular Weight: 358.35

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCC(=O)NCc1ccc(Cl)c(Cl)c1

Standard InChI:  InChI=1S/C19H29Cl2NO/c1-2-3-4-5-6-7-8-9-10-11-19(23)22-15-16-12-13-17(20)18(21)14-16/h12-14H,2-11,15H2,1H3,(H,22,23)

Standard InChI Key:  ZOZRRGJVMWHTIA-UHFFFAOYSA-N

Associated Targets(non-human)

NADH-ubiquinone oxidoreductase chain 1 124 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 358.35Molecular Weight (Monoisotopic): 357.1626AlogP: 6.53#Rotatable Bonds: 12
Polar Surface Area: 29.10Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 6.83CX LogD: 6.83
Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.42Np Likeness Score: -0.82

References

1. Satoh T, Miyoshi H, Sakamoto K, Iwamura H..  (1996)  Comparison of the inhibitory action of synthetic capsaicin analogues with various NADH-ubiquinone oxidoreductases.,  1273  (1): [PMID:8573592] [10.1016/0005-2728(95)00131-x]

Source